Compare BVS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | MLAB |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 461.9M |
| IPO Year | 2016 | 1995 |
| Metric | BVS | MLAB |
|---|---|---|
| Price | $10.41 | $98.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $14.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 440.5K | 82.3K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | ★ 163.46 | 99.24 |
| EPS | 0.33 | ★ 1.95 |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $6.07 |
| Revenue Next Year | $7.06 | $5.41 |
| P/E Ratio | ★ $32.03 | $51.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $59.63 |
| 52 Week High | $10.58 | $128.55 |
| Indicator | BVS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 69.21 | 64.85 |
| Support Level | $8.43 | $69.02 |
| Resistance Level | N/A | $97.56 |
| Average True Range (ATR) | 0.38 | 3.83 |
| MACD | 0.13 | 1.19 |
| Stochastic Oscillator | 83.96 | 81.50 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.